News
Agitation and aggression are challenging behaviors that can happen in people with dementia, especially in Alzheimer’s disease. It can cause you or your relative to act out in different ways. You ...
Hosted on MSN7mon
US retail sales rose 4.13% YoY in October 2024 - MSNOctober’s YoY total sales were the largest since November 2023, when it recorded 4.24% while the YoY increase for core sales was the largest since August 2023, which saw a rise of 4.76%.
By brand, sales for the company’s luxury car brand, Lexus, climbed 39.7% YoY with 70,313 vehicles sold in May. Hino, Toyota’s truck manufacturing arm, recorded a sale volume of 10,563 units, a ...
Lundbeck and Otsuka’s Rexulti has become the first drug to be approved by the FDA to treat agitation associated with Alzheimer’s disease, a common symptom of the neurodegenerative disorder.
The list price of Rexulti is $1,419 per month. However, people can pay much less through a prescription drug plan (PDP), also known as Medicare Part D. According to the manufacturers of the drug ...
Last year, Rexulti pulled in 2.85 billion Danish kroner ($405 million) in sales for Lundbeck. In mid-2022, SVB Securities analysts noted that the agitation indication could bring in peak sales of ...
Year-over-year, sales improved 2.0% (up from 4 million in January 2024). “Mortgage rates have refused to budge for several months despite multiple rounds of short-term interest rate cuts by the ...
The Japanese drugmaker named the disease awareness campaign for Alzheimer’s-associated agitation as a driver of 22% Rexulti sales growth in the quarter. H. Lundbeck Rexulti DTC advertising major ...
Analysts have suggested that approval for AAD could swell sales of Rexulti by $500 million to $1 billion, a big step up for a drug which currently makes around $1.4 billion in annual sales.
Hosted on MSN1mon
Honda two-wheeler sales down by 11% YoY in April 2025. Check out export numbers… - MSNHonda Two-Wheeler India reported sales of 4,80,896 units in April 2025, down 11 ... The two-wheeler manufacturer has seen a 5 per cent YoY slump in terms of exports as the manufacturer sold 60,900 ...
Rexulti (brexpiprazole) is a brand-name oral tablet that’s prescribed for certain mental health conditions. Rexulti has interactions with alcohol, some other drugs, and certain supplements.
Rexulti is supplied as tablets in 0.25mg, 0.5mg, 1mg, 2mg, 3mg, and 4mg dosage strengths. It is also indicated for use as an adjunctive therapy to antidepressants for the treatment of major ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results